Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Agios Pharmaceuticals and Novartis Pharmaceuticals Corporation.
Physicians’ Education Resource®, LLC (PER) is pleased to present an exciting live, continuing medical education (CME)-certified activity titled “Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta.” This live-streamed interactive webcast is led by world renowned Acute Myeloid Leukemia (AML) experts: Richard Stone, MD; Naval Daver, MD; and Etyan Stone, MD.
The Rapid Reviews in Oncology® format is a live-stream, interactive broadcast from a professional studio to rapidly update physicians on data that will have been recently presented at the American Society of Hematology (ASH) Annual Meeting in December 2017. The program will consist of an in-studio panel discussion between AML experts highlighting implications and applications of ground-breaking data in the treatment and management of AML presented at the 2017 ASH Annual Meeting. The program is interactive; participants are invited to submit questions to the panel as they view the live program. The live version will be archived on www.gotoper.com on December 21st for convenient review.
The Rapid Reviews in Oncology® program on AML from ASH will bring conference-caliber education to the convenience of your screen!
This activity is directed toward medical oncologists, oncologist/hematologists and hematologists who treat patients with acute myeloid leukemia. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of leukemia patients will also be invited to participate.
At the conclusion of this activity, participants should be better prepared to:
Richard Stone, MD
Professor of Medicine, Harvard Medical School
Chief of Staff
Director, Adult Leukemia
Dana-Farber Cancer Institute
ASH: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients with GvHD
December 8, 2017
ASH: Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies
December 8, 2017
Addressing Challenges and Personalizing Care in Postsurgical Pain Management - Brunch With the Experts
Dec 29, 2017